Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
17,286,706
-
Share change
-
+3,914,304
-
Total reported value
-
$595,999,178
-
Price per share
-
$34.50
-
Number of holders
-
78
-
Value change
-
+$134,232,969
-
Number of buys
-
51
-
Number of sells
-
29
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q1 2014
As of 31 Mar 2014,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,286,706 shares.
The largest 10 holders included
Polaris Venture Management Co IV LLC, FMR LLC, ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP LLC, Deer VII & Co. Ltd., FRANKLIN RESOURCES INC, QVT Financial LP, JPMORGAN CHASE & CO, and VANGUARD GROUP INC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.